Gotowa bibliografia na temat „HepG2 cells”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Spis treści
Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „HepG2 cells”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Artykuły w czasopismach na temat "HepG2 cells"
Sary, Hanan G., Nahla A. Ayoub, Abdel Nasser B. Singab, Mickey Vinodh i Khaled Y. Orabi. "ISOLATION OF BIOACTIVE COMPOUNDS FROM CENTAUREA AEGYPTIACA". International Journal of Pharmacy and Pharmaceutical Sciences 10, nr 4 (1.04.2018): 1. http://dx.doi.org/10.22159/ijpps.2018v10i4.17528.
Pełny tekst źródłaPang, Ye-Bin, Jian He, Bi-Yu Cui, Sheng Xu, Xi-Lei Li, Man-Ya Wu, Rong Liang i in. "A Potential Antitumor Effect of Dendritic Cells Fused with Cancer Stem Cells in Hepatocellular Carcinoma". Stem Cells International 2019 (1.04.2019): 1–10. http://dx.doi.org/10.1155/2019/5680327.
Pełny tekst źródłaChoi, Hyo-Kyoung, i Min-Yu Chung. "Isoeugenol Inhibits PCSK9 in HepG2 Cells". Journal of the Korean Society of Food Science and Nutrition 49, nr 9 (30.09.2020): 919–24. http://dx.doi.org/10.3746/jkfn.2020.49.9.919.
Pełny tekst źródłaLee, Junmin, Aly Ung, Hanjun Kim, KangJu Lee, Hyun-Jong Cho, Praveen Bandaru, Samad Ahadian, Mehmet R. Dokmeci i Ali Khademhosseini. "Engineering liver microtissues to study the fusion of HepG2 with mesenchymal stem cells and invasive potential of fused cells". Biofabrication 14, nr 1 (30.11.2021): 014104. http://dx.doi.org/10.1088/1758-5090/ac36de.
Pełny tekst źródłaZhou, Shuping, Yongfang Ma, Xueke Liu, Pan Yu, Ning Huang, Li Song, Ruyue Xu, Zhen Huo, Tao Zhu i Xiaolong Tang. "Targeted Delivery of Glypican 3 (GPC3) Antibody-Modified MicroRNA (miR let-7b-5p) Polymer Nanoparticles to Sorafenib-Resistant Hepatsocellular Carcinoma Cells". Journal of Biomedical Nanotechnology 17, nr 4 (1.04.2021): 677–90. http://dx.doi.org/10.1166/jbn.2021.3033.
Pełny tekst źródłaChang, Xiaomin, Xuerong Zhao, Jianping Wang, Shi Ding, Lijun Xiao, Enhong Zhao i Xin Zheng. "Effect of Hsp90 Inhibitor KW-2478 on HepG2 Cells". Anti-Cancer Agents in Medicinal Chemistry 19, nr 18 (7.02.2020): 2231–42. http://dx.doi.org/10.2174/1871520619666191023094610.
Pełny tekst źródłaAbdel Aziz, Mohamed Talaat, Hussien Mostafa Khaled, Ali El Hindawi, Nagwa Kamal Roshdy, Laila A. Rashed, Dina Sabry, Amira A. Hassouna, Fatma Taha i Walaa Ibrahim Ali. "Effect of Mesenchymal Stem Cells and a Novel Curcumin Derivative on Notch1 Signaling in Hepatoma Cell Line". BioMed Research International 2013 (2013): 1–8. http://dx.doi.org/10.1155/2013/129629.
Pełny tekst źródłaNegoro, Ryosuke, Mitsuki Tasaka, Sayaka Deguchi, Kazuo Takayama i Takuya Fujita. "Generation of HepG2 Cells with High Expression of Multiple Drug-Metabolizing Enzymes for Drug Discovery Research Using a PITCh System". Cells 11, nr 10 (18.05.2022): 1677. http://dx.doi.org/10.3390/cells11101677.
Pełny tekst źródłaTian, Sha, Zhuo Liu, Qing Zhou, Ruoxia Wu, Xiaodi Huang, Zicheng Liang, Zhen Zhang i Xuefei Tian. "Upregulation of MiR-340-5p Reverses Cisplatin Sensitivity by Inhibiting the Expression of CDK6 in HepG2 Cells". Folia Biologica 69, nr 2 (13.07.2021): 57–66. http://dx.doi.org/10.3409/fb_69-2.08.
Pełny tekst źródłaAlburae, Najla Ali, i Afrah Eltayeb Mohammed. "Antiproliferative effect of the Red Sea cone snail, Conus geographus". Tropical Journal of Pharmaceutical Research 19, nr 3 (9.04.2020): 577–81. http://dx.doi.org/10.4314/tjpr.v19i3.17.
Pełny tekst źródłaRozprawy doktorskie na temat "HepG2 cells"
呂可欣 i Ho-yan Lui. "Effects of lipoic acid on oxidant-induced cytotoxicity in HepG2 cells". Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2000. http://hub.hku.hk/bib/B31969768.
Pełny tekst źródłaLui, Ho-yan. "Effects of lipoic acid on oxidant-induced cytotoxicity in HepG2 cells". Hong Kong : University of Hong Kong, 2000. http://sunzi.lib.hku.hk/hkuto/record.jsp?B2203240X.
Pełny tekst źródłaVahdati-Mashhadian, Nasser. "Regulation of CYP3A gene expression in human HepG2 hepatoma cells". Thesis, University of Surrey, 2001. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.364817.
Pełny tekst źródłaColton, Heidi Muth. "Dissecting Mechanisms of Toxicity in HepG2 Cells Using Gene Expression Analysis". NCSU, 2002. http://www.lib.ncsu.edu/theses/available/etd-09132002-161850/.
Pełny tekst źródłaEtwebi, Zienab. "Magnesium Regulation of Glucose and Fatty Acid Metabolism in HEPG2 Cells". Case Western Reserve University School of Graduate Studies / OhioLINK, 2011. http://rave.ohiolink.edu/etdc/view?acc_num=case1307564164.
Pełny tekst źródłaWang, Hui. "Molecular mechanisms of oridonin-induced cytotoxicity and apoptosis in HepG2 cells". HKBU Institutional Repository, 2010. http://repository.hkbu.edu.hk/etd_ra/1162.
Pełny tekst źródłaSyed, Noor Afshan. "Regulation of glycogen synthase and glycogen phosphorylase by insulin in HepG2 cells". Thesis, National Library of Canada = Bibliothèque nationale du Canada, 2001. http://www.collectionscanada.ca/obj/s4/f2/dsk3/ftp05/NQ63926.pdf.
Pełny tekst źródłaPortolesi, Roxanne, i roxanne portolesi@flinders edu au. "Fatty acid metabolism in HepG2 cells: Limitations in the accumulation of docosahexaenoic acid in cell membranes". Flinders University. Medicine, 2007. http://catalogue.flinders.edu.au./local/adt/public/adt-SFU20070802.103146.
Pełny tekst źródłaMorton, Latarchal D. "Ceramide stimulates 3 -methylcholanthrene’s ability to induce cytochrome (cyp1a1) p450 in hepg2 cells". DigitalCommons@Robert W. Woodruff Library, Atlanta University Center, 2005. http://digitalcommons.auctr.edu/dissertations/3648.
Pełny tekst źródłaTo, Wing Shu. "Effect of cellular redox and energy states on benzo[a]pyrene induced modes of death in the hepa and the HepG2 cell lines". HKBU Institutional Repository, 2010. http://repository.hkbu.edu.hk/etd_ra/1173.
Pełny tekst źródłaKsiążki na temat "HepG2 cells"
Villeneuve, David J. A comparison of oxidative enzymes in K562 and HepG2 cells. Sudbury, Ont: Laurentian University, 1992.
Znajdź pełny tekst źródłaWhite, Angela T. Characterisation of altered gene expression in response to Oxidative stree in HepG2 cells. Birmingham: University of Birmingham, 2003.
Znajdź pełny tekst źródłaAndreou, Efrosini Roseann. Analysis of CYP7A1 gene regulation in HepG2 cells by reverse-transcriptase polymerase chain reaction. Ottawa: National Library of Canada = Bibliothèque nationale du Canada, 1999.
Znajdź pełny tekst źródłaMusonda, Alam Clement. Quercetin as a modulator of xenobiotic metabolism and reactive oxygen species (ROS) in human hepG2 cells. Birmingham: University of Birmingham, 1998.
Znajdź pełny tekst źródłaLekas, Poli. Analysis of human CYP2E1 mRNA in a HepG2 cell line by reverse transcription-polymerase chain reaction (RT-PCR). Ottawa: National Library of Canada, 1998.
Znajdź pełny tekst źródłaTraynor, Russell Mark. Growth of metabolically active HepG2, human hepatoma, cells in high density cultures. 1996.
Znajdź pełny tekst źródłaRajesan, Ratheishan. Effects of human milk and formula on the transcriptional regulation of cytochrome P450 3A4 in HepG2 cells. 2004.
Znajdź pełny tekst źródłaCzęści książek na temat "HepG2 cells"
Boucher, Philippe, i Hans Gerhard Vogel. "Internalization of Labeled LDL into HepG2 Cells". W Drug Discovery and Evaluation: Pharmacological Assays, 2291–93. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-05392-9_52.
Pełny tekst źródłaBoucher, Philippe, i Hans Gerhard Vogel. "Internalization of Labeled LDL into HepG2 Cells". W Drug Discovery and Evaluation: Pharmacological Assays, 1–2. Berlin, Heidelberg: Springer Berlin Heidelberg, 2015. http://dx.doi.org/10.1007/978-3-642-27728-3_52-1.
Pełny tekst źródłaKelly, Lynne A. "Phytoestrogens Activate the Estrogen Receptor in HepG2 Cells". W Methods in Molecular Biology, 445–55. New York, NY: Springer New York, 2016. http://dx.doi.org/10.1007/978-1-4939-3127-9_35.
Pełny tekst źródłaKumagai, T., K. Takemura, S. Terada, A. Ogawa, M. Miki, M. Sasaki i H. Yamada. "Effect of Silk Protein Sericin on Hepatoblastoma HepG2 Cells". W Animal Cell Technology: Basic & Applied Aspects, 281–85. Dordrecht: Springer Netherlands, 2003. http://dx.doi.org/10.1007/978-94-017-0726-8_49.
Pełny tekst źródłaDonato, María Teresa, Laia Tolosa i María José Gómez-Lechón. "Culture and Functional Characterization of Human Hepatoma HepG2 Cells". W Methods in Molecular Biology, 77–93. New York, NY: Springer New York, 2014. http://dx.doi.org/10.1007/978-1-4939-2074-7_5.
Pełny tekst źródłaSaquib, Quaiser, Maqsood A. Siddiqui, Javed Ahmad, Sabiha M. Ansari, Mohammad Faisal, Rizwan Wahab, Abdulrahman A. Alatar, Abdulaziz A. Al-Khedhairy i Javed Musarrat. "Nickel Oxide Nanoparticles Induced Transcriptomic Alterations in HEPG2 Cells". W Advances in Experimental Medicine and Biology, 163–74. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-72041-8_10.
Pełny tekst źródłaKurowska, Elzbieta M., i John A. Manthey. "Regulation of Lipoprotein Metabolism in HepG2 Cells by Citrus Flavonoids". W Flavonoids in Cell Function, 173–79. Boston, MA: Springer US, 2002. http://dx.doi.org/10.1007/978-1-4757-5235-9_16.
Pełny tekst źródłaOmasa, Takeshi, i Shin Enosawa. "Construction of Liver Model with Genetically Engineered Human HepG2 Cells". W Animal Cell Technology: Basic & Applied Aspects, 25–29. Dordrecht: Springer Netherlands, 2003. http://dx.doi.org/10.1007/978-94-017-0726-8_5.
Pełny tekst źródłaWu, Defeng, i Arthur I. Cederbaum. "Development and Properties of HepG2 Cells That Constitutively Express CYP2E1". W Alcohol, 137–50. Totowa, NJ: Humana Press, 2008. http://dx.doi.org/10.1007/978-1-59745-242-7_11.
Pełny tekst źródłaKurowska, Elzbieta M., Carina Banh, Shin Hasegawa i Gary D. Manners. "Regulation of Apo B Production in HepG2 Cells by Citrus Limonoids". W ACS Symposium Series, 175–84. Washington, DC: American Chemical Society, 2000. http://dx.doi.org/10.1021/bk-2000-0758.ch013.
Pełny tekst źródłaStreszczenia konferencji na temat "HepG2 cells"
Шунькина, Дарья Александровна, Анастасия Ярославовна Дахневич, Ольга Геннадьевна Хазиахматова, Егор Олегович Шунькин i Валерия Владимировна Шуплецова. "STUDY OF CELL MODELS OF HEPG2 STEATOSIS AND STEATOHEPATITIS VIABILITY". W Современные научные подходы в фундаментальных и прикладных исследованиях: сборник статей международной научной конференции (СанктПетербург, Декабрь 2022). Crossref, 2023. http://dx.doi.org/10.37539/221216.2022.12.14.006.
Pełny tekst źródłaFakhar-e-Alam, M., Syed M. Usman Ali, S. Ali, S. Firdous, M. Atif, Z. H. Ibupoto, M. Willander, M. Kashif i U. Hashim. "Photodynamic damage in liver carcinoma HepG2 cells". W 2012 International Conference on Biomedical Engineering (ICoBE). IEEE, 2012. http://dx.doi.org/10.1109/icobe.2012.6179012.
Pełny tekst źródłaGao, Shiyong, Yubin Ji, Chenfeng Ji i Xiang Zou. "Induction of Apoptosis in HepG2 Cells by Solanine". W 2009 3rd International Conference on Bioinformatics and Biomedical Engineering (iCBBE). IEEE, 2009. http://dx.doi.org/10.1109/icbbe.2009.5162948.
Pełny tekst źródłaNiemietz, C., S. Guttmann, V. Sandfort i H. Schmidt. "SERPINA1 levels dictate TTR expression in HepG2 cells". W 35. Jahrestagung der Deutschen Arbeitsgemeinschaft zum Studium der Leber. Georg Thieme Verlag KG, 2019. http://dx.doi.org/10.1055/s-0038-1677092.
Pełny tekst źródłaVonarx-Coinsmann, Veronique, Marie-Therese Foultier, Leonor X. de Brito, Laurent Morlet i Thierry Patrice. "HepG2 human hepatocarcinomas cells sensitization by endogenous porphyrins". W Fifth International Photodynamic Association Biennial Meeting, redaktor Denis A. Cortese. SPIE, 1994. http://dx.doi.org/10.1117/12.203358.
Pełny tekst źródłaMeng, Xiang-Ping, Zhen Zhang, Tong-sheng Chen, Yi-fei Wang i Zhi-ping Wang. "Anti-hepatocarcinoma effects of resveratrol nanoethosomes against human HepG2 cells". W SPIE BiOS, redaktor Wei R. Chen. SPIE, 2017. http://dx.doi.org/10.1117/12.2251110.
Pełny tekst źródłaGao, Jia-min, Zhi-Ping Wang, Xiang-Ping Meng, Tong-Sheng Chen i Yi-Fei Wang. "Anti-hepatocarcinoma effects of puerarin-nanoethosomes against human HepG2 cells". W Nanophotonics and Micro/Nano Optics IV, redaktorzy Zhiping Zhou i Kazumi Wada. SPIE, 2018. http://dx.doi.org/10.1117/12.2500149.
Pełny tekst źródłama, zili, Siu Kai Kong i Kam Tai Chan. "Whole-cell ROS rise in HepG2 cells induced by localized fs laser irradiation". W Asia Communications and Photonics Conference. Washington, D.C.: OSA, 2012. http://dx.doi.org/10.1364/acp.2012.ath2e.2.
Pełny tekst źródłaMa, Zi Li, Siu Kai Kong i Kam Tai Chan. "Whole-cell ROS rise in HepG2 cells induced by localized fs laser irradiation". W Asia Communications and Photonics Conference. Washington, D.C.: OSA, 2012. http://dx.doi.org/10.1364/acpc.2012.ath2e.2.
Pełny tekst źródłaBajaj, M. S., S. V. Rana, R. B. Wysolmerski i S. P. Bajaj. "INHIBITOR OF THE FACTOR VIIA-TISSUE FACTOR COMPLEX IS REDUCED IN PATIENTS WITH DISSEMINATED INTRAVASCULAR COAGULATION BUT NOT IN PATIENTS WITH SEVERE HEPATOCELLULAR DISEASE". W XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643916.
Pełny tekst źródłaRaporty organizacyjne na temat "HepG2 cells"
Li, Jing. Effects of artemisinin on proliferation and apoptosis of human liver cancer HepG2 cells: a protocol of systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, kwiecień 2020. http://dx.doi.org/10.37766/inplasy2020.4.0075.
Pełny tekst źródła